These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 25524720)

  • 1. Animal models of tuberculosis: Guinea pigs.
    Clark S; Hall Y; Williams A
    Cold Spring Harb Perspect Med; 2014 Dec; 5(5):a018572. PubMed ID: 25524720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.
    Williams A; Hatch GJ; Clark SO; Gooch KE; Hatch KA; Hall GA; Huygen K; Ottenhoff TH; Franken KL; Andersen P; Doherty TM; Kaufmann SH; Grode L; Seiler P; Martin C; Gicquel B; Cole ST; Brodin P; Pym AS; Dalemans W; Cohen J; Lobet Y; Goonetilleke N; McShane H; Hill A; Parish T; Smith D; Stoker NG; Lowrie DB; Källenius G; Svenson S; Pawlowski A; Blake K; Marsh PD
    Tuberculosis (Edinb); 2005; 85(1-2):29-38. PubMed ID: 15687025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.
    Brandt L; Skeiky YA; Alderson MR; Lobet Y; Dalemans W; Turner OC; Basaraba RJ; Izzo AA; Lasco TM; Chapman PL; Reed SG; Orme IM
    Infect Immun; 2004 Nov; 72(11):6622-32. PubMed ID: 15501795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential proteomics approach to identify putative protective antigens of Mycobacterium tuberculosis presented during early stages of macrophage infection and their evaluation as DNA vaccines.
    Sharma S; Rajmani RS; Kumar A; Bhaskar A; Singh A; Manivel V; Tyagi AK; Rao KV
    Indian J Exp Biol; 2015 Jul; 53(7):429-39. PubMed ID: 26245027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model.
    Horwitz MA; Harth G; Dillon BJ; Maslesa-Galic' S
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13853-8. PubMed ID: 11095745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge.
    Vipond J; Vipond R; Allen-Vercoe E; Clark SO; Hatch GJ; Gooch KE; Bacon J; Hampshire T; Shuttleworth H; Minton NP; Blake K; Williams A; Marsh PD
    Vaccine; 2006 Sep; 24(37-39):6340-50. PubMed ID: 16781800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guinea Pig Model of Mycobacterium tuberculosis Infection.
    Creissen E; Izzo L; Dawson C; Izzo AA
    Curr Protoc; 2021 Dec; 1(12):e312. PubMed ID: 34941021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity.
    Horwitz MA; Harth G; Dillon BJ; Maslesa-Galić S
    Vaccine; 2006 Jan; 24(4):443-51. PubMed ID: 16125825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant tuberculosis vaccine AEC/BC02 induces antigen-specific cellular responses in mice and protects guinea pigs in a model of latent infection.
    Lu JB; Chen BW; Wang GZ; Fu LL; Shen XB; Su C; Du WX; Yang L; Xu M
    J Microbiol Immunol Infect; 2015 Dec; 48(6):597-603. PubMed ID: 24863497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein LpqS deficient M. tuberculosis mutant is attenuated for virulence in vivo and shows protective efficacy better than BCG in guinea pigs.
    Sakthi S; Palaniyandi K; Gupta UD; Gupta P; Narayanan S
    Vaccine; 2016 Feb; 34(6):735-43. PubMed ID: 26768127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse and guinea pig models for testing new tuberculosis vaccines.
    Orme IM
    Tuberculosis (Edinb); 2005; 85(1-2):13-7. PubMed ID: 15687022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacing, reducing and refining the use of animals in tuberculosis vaccine research.
    Tanner R; McShane H
    ALTEX; 2017; 34(1):157-166. PubMed ID: 27667476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel tuberculosis vaccines on the horizon.
    Parida SK; Kaufmann SH
    Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of Mycobacterium indicus pranii against tuberculosis and underlying local lung immune responses in guinea pig model.
    Gupta A; Ahmad FJ; Ahmad F; Gupta UD; Natarajan M; Katoch VM; Bhaskar S
    Vaccine; 2012 Sep; 30(43):6198-209. PubMed ID: 22871353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-formulation of selected DNA vaccine candidates and their evaluation as protein vaccines using a guinea pig aerosol infection model of tuberculosis.
    Vipond J; Clark SO; Hatch GJ; Vipond R; Marie Agger E; Tree JA; Williams A; Marsh PD
    Tuberculosis (Edinb); 2006; 86(3-4):218-24. PubMed ID: 16520093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis.
    Sander P; Clark S; Petrera A; Vilaplana C; Meuli M; Selchow P; Zelmer A; Mohanan D; Andreu N; Rayner E; Dal Molin M; Bancroft GJ; Johansen P; Cardona PJ; Williams A; Böttger EC
    Vaccine; 2015 Mar; 33(11):1353-9. PubMed ID: 25657094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of vaccine testing at three laboratories using the guinea pig model of tuberculosis.
    Grover A; Troudt J; Arnett K; Izzo L; Lucas M; Strain K; McFarland C; Hall Y; McMurray D; Williams A; Dobos K; Izzo A
    Tuberculosis (Edinb); 2012 Jan; 92(1):105-11. PubMed ID: 21962569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis.
    Gong W; Liang Y; Wu X
    Biomed Res Int; 2020; 2020():4263079. PubMed ID: 32025519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis vaccine development: The development of novel (preclinical) DNA vaccine.
    Okada M; Kita Y
    Hum Vaccin; 2010 Apr; 6(4):297-308. PubMed ID: 20372079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.